| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adjunct Analgesic Use for Acute Pain in the Emergency Department
|
Priano, James
|
|
2017
|
52 |
2 |
p. 138-143
|
artikel
|
| 2 |
Approvals, Submission, and Important Labeling Changes for US Marketed Pharmaceuticals
|
|
|
2017
|
52 |
2 |
p. 151-152
|
artikel
|
| 3 |
Considerations for Hospital Policies regarding Medical Cannabis Use
|
Borgelt, Laura M.
|
|
2017
|
52 |
2 |
p. 89-90
|
artikel
|
| 4 |
Drug Pricing Transparency: The New Retail Revolution
|
Dana, Kaitlyn N.
|
|
2017
|
52 |
2 |
p. 155-159
|
artikel
|
| 5 |
Irinotecan Liposome Injection
|
Baker, Danial E.
|
|
2017
|
52 |
2 |
p. 144-150
|
artikel
|
| 6 |
Navigating the Institutional Review Board (IRB) Process for Pharmacy-Related Research
|
Phillips, Marjorie Shaw
|
|
2017
|
52 |
2 |
p. 105-116
|
artikel
|
| 7 |
Pharmacists and Pediatric Medication Adherence: Bridging the Gap
|
El-Rachidi, Sarah
|
|
2017
|
52 |
2 |
p. 124-131
|
artikel
|
| 8 |
Preventing 10-fold Dosage Errors; Controlled Substances at Bedside or Procedural Area; Genvoya-Stribild Mix-up; Should Transdermal Fentanyl be Stocked in the ED?
|
Cohen, Michael R.
|
|
2017
|
52 |
2 |
p. 91-93
|
artikel
|
| 9 |
Procarbazine, Lomustine, and Vincristine (PCV) Regimen for Central Nervous System Tumors
|
Solimando, Dominic A.
|
|
2017
|
52 |
2 |
p. 98-104
|
artikel
|
| 10 |
Rivaroxaban-Induced DRESS; Serotonin Syndrome Induced by Paliperidone; Piperacillin-Tazobactam–Induced Nephritis and Hepatitis; Brentuximab-Induced Hand-Foot Syndrome; Valproic Acid–Induced Hyperkalemia
|
Mancano, Michael A.
|
|
2017
|
52 |
2 |
p. 94-97
|
artikel
|
| 11 |
Student Preparation for PGY1 Residency Training by US Colleges of Pharmacy: Survey of the Residency Program Director Perspective
|
Mutz, Alyssa B.
|
|
2017
|
52 |
2 |
p. 117-123
|
artikel
|
| 12 |
Summaries of Safety Labeling Changes Approved by the FDA: Boxed Warnings Highlights October - December 2016
|
Rose, Brenda J.
|
|
2017
|
52 |
2 |
p. 153-154
|
artikel
|
| 13 |
Virtual Reality and Pharmacy: Opportunities and Challenges
|
Fox, Brent I.
|
|
2017
|
52 |
2 |
p. 160-161
|
artikel
|
| 14 |
Y-site Incompatibility between Premix Concentrations of Vancomycin and Piperacillin-Tazobactam: Do Current Compatibility Testing Methodologies Tell the Whole Story?
|
Kufel, Wesley D.
|
|
2017
|
52 |
2 |
p. 132-137
|
artikel
|
Tijdschrift beschrijving